Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorDama, Aida
dc.contributor.authorShpati, Kleva
dc.contributor.authorDaliu, Patricia
dc.contributor.authorDümür, Şeyma
dc.contributor.authorGorica, Era
dc.contributor.authorSantini, Antonello
dc.date.accessioned2024-04-16T13:15:32Z
dc.date.available2024-04-16T13:15:32Z
dc.date.issued2024en_US
dc.identifier.citationDama, A., Shapti, K., Daliu, P., Dümür, Ş., Gorica, E., & Santini, A. (2024). Targeting Metabolic Diseases: The Role of Nutraceuticals in Modulating Oxidative Stress and Inflammation. NUTRIENTS, 16(4), 1-18. https://doi.org/10.3390/nu16040507en_US
dc.identifier.issn2072-6643
dc.identifier.urihttps://hdl.handle.net/20.500.12900/340
dc.description.abstractThe escalating prevalence of metabolic and cardiometabolic disorders, often characterized by oxidative stress and chronic inflammation, poses significant health challenges globally. As the traditional therapeutic approaches may sometimes fall short in managing these health conditions, attention is growing toward nutraceuticals worldwide; with compounds being obtained from natural sources with potential therapeutic beneficial effects being shown to potentially support and, in some cases, replace pharmacological treatments, especially for individuals who do not qualify for conventional pharmacological treatments. This review delves into the burgeoning field of nutraceutical-based pharmacological modulation as a promising strategy for attenuating oxidative stress and inflammation in metabolic and cardiometabolic disorders. Drawing from an extensive body of research, the review showcases various nutraceutical agents, such as polyphenols, omega-3 fatty acids, and antioxidants, which exhibit antioxidative and anti-inflammatory properties. All these can be classified as novel nutraceutical-based drugs that are capable of regulating pathways to mitigate oxidative-stress- and inflammation-associated metabolic diseases. By exploring the mechanisms through which nutraceuticals interact with oxidative stress pathways and immune responses, this review highlights their potential to restore redox balance and temper chronic inflammation. Additionally, the challenges and prospects of nutraceutical-based interventions are discussed, encompassing bioavailability enhancement, personalized treatment approaches, and clinical translation. Through a comprehensive analysis of the latest scientific reports, this article underscores the potential of nutraceutical-based pharmacological treatment modulation as a novel avenue to fight oxidative stress and inflammation in the complex landscape of metabolic disorders, particularly accentuating their impact on cardiovascular health.en_US
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.relation.isversionof10.3390/nu16040507en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectİltihapen_US
dc.subjectInflammationen_US
dc.subjectOksidatif stresen_US
dc.subjectOxidative stressen_US
dc.subjectNutrasötikleren_US
dc.subjectNutraceuticalsen_US
dc.titleTargeting Metabolic Diseases: The Role of Nutraceuticals in Modulating Oxidative Stress and Inflammationen_US
dc.typearticleen_US
dc.departmentİstanbul Atlas Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümüen_US
dc.authoridhttps://orcid.org/0000-0001-8893-2926en_US
dc.contributor.institutionauthorDümür, Şeyma
dc.identifier.volume16en_US
dc.identifier.issue4en_US
dc.identifier.startpage1en_US
dc.identifier.endpage18en_US
dc.relation.journalNUTRIENTSen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster